CTMX
Cytomx Therapeutics
$3.25
+$0.01 (+0.31%)Jul 27, 2026
Key metrics
The numbers that frame CTMX today
- Market cap
- $707.53M
- P/E (TTM)
- -12.0
- EV / FCF
- -8.5
- Gross margin
- 100%
- EV / Sales
- 19.1
- ROIC
- -41.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.72
- 52wk High
- $8.21
Growth
Revenue and earnings trend for CTMX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CTMX
Is Cytomx Therapeutics a good buy?
No. Cytomx Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Cytomx Therapeutics is selling at a very high price.
What is the market capitalization of CTMX?
Cytomx Therapeutics's market capitalization is $707.53M.
What is the P/E ratio for CTMX stock?
Cytomx Therapeutics's current P/E ratio is -12.
What is the 52-week high for CTMX stock?
The 52-week high for Cytomx Therapeutics is $8.21. The current close of $3.25 is 60.4% below that high.
What is the 52-week low for CTMX stock?
The 52-week low for Cytomx Therapeutics is $1.72. The current close of $3.25 is 89% above that low.
Does CTMX stock pay dividends?
Cytomx Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CTMX?
Cytomx Therapeutics's Debt / Equity ratio is 0.01.